Skip to Main Content
A service of the U.S. National Institutes of Health
Example: "Heart attack" AND "Los Angeles"
Search for studies:
Advanced Search
Help
Studies by Topic
Glossary
Find Studies
Basic Search
Advanced Search
See Studies by Topic
See Studies on a Map
How to Search
How to Use Search Results
How to Find Results of Studies
How to Read a Study Record
About Clinical Studies
Learn About Clinical Studies
Other Sites About Clinical Studies
Glossary of Common Site Terms
Submit Studies
Why Should I Register and Submit Results?
FDAAA 801 Requirements
How to Apply for an Account
How to Register Your Study
How to Edit Your Study Record
How to Submit Your Results
Frequently Asked Questions
Support Materials
Training Materials
Resources
Selected Publications
Clinical Alerts and Advisories
RSS Feeds
Trends, Charts, and Maps
Downloading Content for Analysis
About This Site
ClinicalTrials.gov Background
About the Results Database
History, Policies, and Laws
Media/Press Resources
Linking to This Site
Terms and Conditions
Disclaimer
Text Size
Make bigger
Make smaller
Reset
close
Home
Find Studies
Search Results
268 studies found for
: "Hemophilia A"
Modify this search
|
How to Use Search Results
List
By Topic
On a Map
Search Details
Show Display Options
Subscribe to RSS
Create an RSS feed from your search for:
"Hemophilia A"
Need help? See
RSS Feeds
Choose a feed type:
Show studies that were
first received
in the last 14 days
Show studies that were
added
or
modified
in the last 14 days
Cancel
Download
Download the search results for:
"Hemophilia A" (268 records)
Need help? See
Downloading Content for Analysis
Number of Studies:
Top 10 Studies
Top 100 Studies
20 Shown Studies
268 Found Studies
Download Content:
Download All Study Fields as XML
Download All Study and Results Fields as XML
Download Selected Fields:
Select fields:
2 Shown Fields
21 Available Fields
Select field format:
Plain text
Tab-separated values
Comma-separated Values
XML
Zip file readers with free trial periods:
WinZip
or
PKZip
Cancel
Display Options
Study Details
Condition
Intervention
Study Type
Phase
Sponsor/Collaborators
Funder Type
Study Design
Outcome Measures
Participant Details
Number Enrolled
Gender
Age Group
Identifiers
NCT Number
Other IDs
Title Acronym
Dates
Study Start
Primary Completion
Study Completion
First Received
Last Updated
Last Verified
Results First Received
Cancel
Include only
open studies
Exclude studies with
unknown status
Rank
Status
Study
1
Completed
Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor
Conditions:
Hemophilia A; Hemophilia B; (High-titer) Factor VIII Inhibitor; (High-titer) Factor IX Inhibitor
Intervention:
Biological: Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)
2
Active, not recruiting
Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A
Condition:
Hemophilia A
Intervention:
Biological: OBI-1
3
Recruiting
Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A
Condition:
Hemophilia A
Intervention:
Biological: OBI-1
4
Terminated
Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A
Condition:
Hemophilia A
Interventions:
Drug: Rituxan; Drug: prednisone
5
Completed
Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A
Condition:
Hemophilia A
Intervention:
Drug: GreenGene
6
Recruiting
Study of Recombinant Coagulation Factor VIII Fc Fusion Protein, BIIB 031, in Pediatric PTP Subjects With Hemophilia A
Condition:
Hemophilia A
Intervention:
Drug: rFVIIIFc
7
Completed
Has Results
Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery
Condition:
Hemophilia A
Intervention:
Biological: ReFacto AF
8
Recruiting
Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery
Condition:
Hemophilia A
Intervention:
Drug: Recombinant Protein-Free Factor VIII (rAHF-PFM)
9
Completed
Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A
Condition:
Hemophilia A
Intervention:
Drug: Antihemophilic factor, recombinant, manufactured protein-free
10
Completed
Has Results
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
Condition:
Hemophilia A
Intervention:
Biological: Recombinant Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM)
11
Completed
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
Condition:
Hemophilia A
Interventions:
Drug: ReFacto; Drug: Advante
12
Completed
Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101
Condition:
Hemophilia A
Intervention:
Drug: Antihemophilic factor, recombinant, manufactured protein-free
13
Completed
Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A
Condition:
Hemophilia A
Interventions:
Genetic: ReFacto AF; Genetic: B-Domain deleted Recombinant Factor VIII; Genetic: BDDrFVIII
14
Active, not recruiting
Health Related Quality of Life of Youth and Young Adults With Hemophilia A
Condition:
Hemophilia A
Intervention:
15
Completed
Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery
Condition:
Hemophilia A
Intervention:
Drug: ReFacto
16
Completed
Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients
Condition:
Hemophilia A
Intervention:
Drug: Human Plasma-Derived Coagulation Factor VIII Concentrate (Virus Inactivated by Polysorbate 80 Treatment and Vapor Heat Treatment)
17
Completed
Clot Formation and Clot Stability in Patients With Severe Haemophilia A
Condition:
Hemophilia A
Intervention:
Drug: ReFacto (Recombinant factor VIII) and Tranexamic acid
18
Completed
Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901
Condition:
Hemophilia A
Intervention:
Drug: Antihemophilic factor, recombinant, manufactured protein-free
19
Active, not recruiting
rFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors
Condition:
Hemophilia A With Inhibitors
Intervention:
Drug: recombinant activated factor VII
20
Completed
Has Results
Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A
Condition:
Hemophilia A
Intervention:
Drug: Antihemophilic factor, recombinant, manufactured protein-free
To Top
Previous Page
Studies Shown (1-20)
Next Page (21-40)
†
Indicates status has not been verified in more than two years
To Top
Copyright
Privacy
Accessibility
Viewers & Players
Freedom of Information Act
USA.gov
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services